CVE-2026-17222

CVE-2026-17222 is a medium-severity vulnerability in Ibm I with a CVSS 3.x base score of 4.3. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-89.

Key facts

Description

IBM i 7.6, 7.5, 7.4, and 7.3 could allow a remote authenticated attacker to modify data in certain SQL tables due to improper neutralization of special elements used in an SQL command.

Frequently asked questions

What is CVE-2026-17222?
IBM i 7.6, 7.5, 7.4, and 7.3 could allow a remote authenticated attacker to modify data in certain SQL tables due to improper neutralization of special elements used in an SQL command.
How severe is CVE-2026-17222?
CVE-2026-17222 has a CVSS 3.x base score of 4.3, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is none, integrity low, and availability none.
Is CVE-2026-17222 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (17th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2026-17222?
CVE-2026-17222 affects Ibm I. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2026-17222?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2026-17222 published?
CVE-2026-17222 was published on 2026-08-12 and last updated on 2026-08-13.

References

Affected products (1)

More vulnerabilities in Ibm I

All CVEs affecting Ibm I →

Other CWE-89 (SQL Injection) vulnerabilities

Browse all CWE-89 (SQL Injection) vulnerabilities →